Tenex Health Inc., led by former Boston Scientific executive Jagi Gill, raises $1.3 million in an equity sale.
By Thomas Lee
Tenex Health Inc. raised $1.3 million from the sale of equity, according to a filing with the Securities & Exchange Commission.
The Rochester, Minn.-based biotech start-up, which is seeking a total of $2 million, is developing treatments for sports-related injuries such as tendinitis.
Founder and CEO Jagi Gill did not return a phone call seeking comment.
Medical device giant Medtronic says its European CE Mark is the 1st ever regulatory approval for...
Johnson & Johnson subsidiary Biosense Webster enrolls its 1st patient in the reMARQable clinical...
Four health systems create a collaborative group as part of the Premier network
Agea Medical is $2 million shy of its $8 million funding round goal
The FDA's Dental Products Panel is scheduled to deliberate on whether the agency should lower blade-...